|
Pasritamig Clinical Trials
3 actively recruiting trials across 3 locations
Also known as: JNJ-78278343
Los Angeles, California1 trial
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
Valkyrie Clinical Trials
Phase 3
Aurora, Colorado1 trial
A Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
Rocky Mountain Cancer Centers
Phase 3
Sarasota, Florida1 trial
A Study of Pasritamig (JNJ-78278343) in Combination With JNJ-86974680 for Treatment of Prostate Cancer
Florida Cancer Specialists
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.